Sygnity to take over Comarch's HIS segment - what's next for the eHealth market
Sygnity has entered into a conditional preliminary agreement with Comarch for the purchase of 100 per cent of the shares in Comarch HIS, valuing the transaction at approximately PLN 28 million (subject to adjustments). The final agreement is expected to be concluded by 31 March 2026, subject to the completion of the spin-off of the HIS assets by Comarch and the necessary certifications.
Comarch explains the decision to sell as part of a review of strategic options for the public administration and eHealth segments, announced at the beginning of 2025. The HIS segment will be spun off into a new company, 100% of whose shares will be acquired by Sygnity. The agreement provides for price settlement mechanisms – part of the consideration is to be adjusted as at the date of the transaction and then settled after four months.
The transaction is part of the observed consolidation of the medical systems market. The eHealth segment, especially HIS systems, is characterised by a high level of specialisation and entry barriers related to regulations, interoperability and data security requirements. Sygnity gains a ready portfolio of clients and technological competence, which may strengthen its position against competitors such as Asseco in the healthcare solutions market.
For Comarch, the sale of HIS could mean an opportunity to focus resources on key pillars of the business, such as ERP or infrastructure, in line with the new strategy. However, it is worth noting that Comarch’s revenues from the medical area were relatively low in 2024, which may suggest a limited market to serve or problems with scaling this segment.
The key conditions for the execution of the transaction will remain: proper separation of the HIS, regulatory and technical compliance and the ability to integrate into the Sygnity structure. If it can be carried out smoothly, the transaction could prove to be a boost for consolidation in the Polish eHealth sector, although integration and technology risks are not insignificant.
